Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT)

CUSIP: 42225T107

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
73,581,273
Total 13F shares
51,714,283
Share change
+1,624,562
Total reported value
$365,529,299
Put/Call ratio
0.54%
Price per share
$7.07
Number of holders
164
Value change
+$10,713,924
Number of buys
81
Number of sells
68

Quarterly Holders Quick Answers

What is CUSIP 42225T107?
CUSIP 42225T107 identifies HCAT - Health Catalyst, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT) as of Q4 2024

As of 31 Dec 2024, Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT) was held by 164 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,714,283 shares. The largest 10 holders included BlackRock, Inc., First Light Asset Management, LLC, VANGUARD GROUP INC, Impax Asset Management Group plc, Daventry Group, LP, Alyeska Investment Group, L.P., MILLENNIUM MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, PRIMECAP MANAGEMENT CO/CA/, and KENNEDY CAPITAL MANAGEMENT LLC. This page lists 165 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.